Cargando…

Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2

BACKGROUND: This study explores the risk factors associated with viral shedding time in elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron. METHODS: Participants infected with SARS-CoV-2 omicron were enrolled in a retrospective study, and divi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Weijie, Yang, Xiaosheng, Jiang, Xiufeng, Duan, Zhixin, Wang, Wei, Sun, Zhaoliang, Chen, Wanghao, Zhang, Wenchuan, Xu, Jie, Cheng, Juan, Yuan, Xiaoling, Li, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878338/ https://www.ncbi.nlm.nih.gov/pubmed/36711364 http://dx.doi.org/10.3389/fpubh.2022.1087800

Ejemplares similares

The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
por: Zhong, Weijie, et al.
Publicado: (2022)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
por: Selvavinayagam, Sivaprakasam T., et al.
Publicado: (2022)

Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study
por: Zhang, Wen, et al.
Publicado: (2022)

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
por: Yao, Lin, et al.
Publicado: (2022)

Understanding the viral shedding time of Omicron variant BA.2 infection in Shanghai: A population-based observational study
por: Lu, Zhenzhen, et al.
Publicado: (2023)

Case report: Severe acute hepatitis in a 22-month-old Chinese boy with Omicron sub-variant BA.2.38
por: Chen, Xinying, et al.
Publicado: (2022)

Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients
por: He, Shaojun, et al.
Publicado: (2022)

Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
por: Wu, Jun, et al.
Publicado: (2023)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
por: Tong, Chengzhuo, et al.
Publicado: (2022)

The relationship between early isolation and the duration of viral shedding of mild and asymptomatic infection with SARS-CoV-2 Omicron BA.2 variant
por: Yin, Yong, et al.
Publicado: (2022)

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
por: Boucau, Julie, et al.
Publicado: (2022)

P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE
por: Ikeda, Daisuke, et al.
Publicado: (2023)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
por: Duan, Minrun, et al.
Publicado: (2023)

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
por: Shuai, Huiping, et al.
Publicado: (2023)

Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
por: Yang, Peng, et al.
Publicado: (2023)

Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai
por: Li, Ran, et al.
Publicado: (2023)

Viral load of SARS‐CoV‐2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
por: Takatsuki, Yuna, et al.
Publicado: (2023)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
por: Pedersen, Rune M., et al.
Publicado: (2022)

Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market
por: Luo, Mingyu, et al.
Publicado: (2023)

Comparison of SARS-CoV-2 Viral Loads in the Nasal Mucosa of Patients Infected With BA.1, BA.2, or BA.5 Omicron Lineages
por: Tozer, Kyla, et al.
Publicado: (2022)

Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
por: Saade, Carla, et al.
Publicado: (2022)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

Multiple drugs: Diarrhoea and prolonged viral shedding: 2 case reports
Publicado: (2020)

Prolonged SARS-CoV2 Viral Shedding in an Elderly Patient
por: Jariwal, Roopam, et al.
Publicado: (2021)

278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2
por: Tarabay, Jessica, et al.
Publicado: (2021)

Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2023)

First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
por: Colson, Philippe, et al.
Publicado: (2022)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
por: Xu, Ren, et al.
Publicado: (2022)

Corrigendum: Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market
por: Luo, Mingyu, et al.
Publicado: (2023)

Omicron variant: assessing the duration of viral shedding and its implications
por: Cevik, Muge, et al.
Publicado: (2023)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
por: Xu, Cong, et al.
Publicado: (2023)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases
por: Lentini, Antonio, et al.
Publicado: (2022)

Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study
por: Pei, Lei, et al.
Publicado: (2023)

Genomic characteristics and viral load dynamics of a SARS-CoV-2 Omicron BA.2.2 variant from a hospitalized patient treated with molnupiravir
por: Chan, Wai Sing, et al.
Publicado: (2022)

Prolonged viral shedding of SARS-CoV-2 in patients with acute leukemia
por: Altamirano-Molina, Milagros, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fng202p2gr60ik2f58mlrgi7tf